Related Experiment Video
Updated: May 7, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Catastrophic Antiphospholipid Syndrome: When STEMI Is Not Atherosclerotic
Sarah H Choudhury1, Ava Wexler1, Manali Shah1
1Division of Cardiology, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
Antiphospholipid syndrome (APS) can cause ST-segment elevation myocardial infarction (STEMI) even without typical risk factors. This case highlights catastrophic APS presenting with arterial thromboses, emphasizing the need for prompt evaluation and treatment.
Area of Science:
- Cardiology
- Rheumatology
- Vascular Medicine
Background:
- Antiphospholipid syndrome (APS) is a rare cause of ST-segment elevation myocardial infarction (STEMI) in individuals lacking traditional cardiovascular risk factors.
- Catastrophic APS (CAPS) involves widespread organ damage due to microvascular and macrovascular thrombosis.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
06:59Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease I: Introduction
Transient Ischemic Attack l: Introduction